
    
      The maximum number of subjects enrolled in this study is 33.

      The following number of subjects will be recruited in the different cohorts:

        -  Dose escalation cohorts (Phase 1a): 3 - 24 Subjects

        -  Repeated injection cohorts (Phase 1b): 3 Subjects

        -  Expansion cohort: 6 Subjects
    
  